M&A Snapshot: Jazz Pharmaceuticals acquires Chimerix at a 72% premium deal M&A Snapshot: Jazz Pharmaceuticals acquires Chimerix at a 72% premium deal Post Contentjazz, cmrxRead More You might also be interested in reading Venus Protocol hit by $3.7M in ‘supply cap’ attack. March 5, 2025 In Mainstream ← Previous post Next post →